At the JP Morgan Healthcare Conference in January, pharmaphorum editor-in-chief Jonah Comstock caught up with Bradley Bostic, ...

Healthcare Analysts provide expert insights on current and emerging treatments for Systemic Mastocytosis (relevant companies Blueprint ...

Jennifer Schneider is the CEO of UK-based Centauri Therapeutics, which is developing an immunotherapy for infectious disease that can help patients who don’t respond well to traditional ...

Lico, President and Chief Executive Officer, and Olumide Soroye, President and Chief Executive Officer of Intelligent Operating Solutions and Advanced Healthcare Solutions, will be presenting at the J ...

During the week of the 2025 J.P. Morgan Healthcare Conference in San Francisco, life sciences partners Suzanne Filippi and Laurie Burlingame led ...

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a cash infusion to head to clinical trials.

The CARAai platform supports a wide range of enterprise healthcare and life sciences use cases and solutions. Over the course of 2025, ConcertAI will be launching a series of new AI SaaS solutions ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

Switching to IMVT-1402 extends the head starts Immunovant has already ceded to its rivals. Argenx won FDA approval for ...

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

OSI Systems, Inc. (NASDAQ: OSIS), today announced that Alan Edrick, CFO, will participate in a fireside chat at the J.P. Morgan 2025 Industrials Conference on Tuesday ... applications in the homeland ...